| Nov 19 |
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
|
| Nov 9 |
Analysts Have Made A Financial Statement On Arcus Biosciences, Inc.'s (NYSE:RCUS) Third-Quarter Report
|
| Nov 7 |
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
|
| Nov 7 |
Arcus Biosciences, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 7 |
Arcus Biosciences, Inc. (RCUS) Q3 2024 Earnings Call Transcript
|
| Nov 6 |
Arcus Biosciences GAAP EPS of -$1.00 beats by $0.04, revenue of $48M beats by $9.05M
|
| Nov 6 |
Arcus Biosciences, Inc. (RCUS) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 6 |
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
|
| Nov 5 |
Arcus Biosciences Q3 2024 Earnings Preview
|
| Nov 5 |
Arcus says Gilead-partnered cancer therapy cut death risk by 36%
|
